NCT05623852 (OFCS) is a NA clinical trial of fucoidan in Cachexia, sponsored by Taipei Medical University WanFang Hospital.

Who is sponsoring NCT05623852?

NCT05623852 is sponsored by Taipei Medical University WanFang Hospital.

What drugs are being tested in NCT05623852?

Interventions in NCT05623852: fucoidan.

Is NCT05623852 still recruiting?

NCT05623852 is currently status unknown. Last updated 21 November 2022.

Last reviewed 2022-11-21 · How we verify

NCT05623852: OFCS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Oligo-Fucoidan in Cancer Cachexia and Sarcopenia

Status unknown NA Last updated 21 November 2022

What this trial tests

NA trial testing fucoidan in Cachexia in 100 participants. Status unknown.

Timeline

30 January 2022

Primary endpoint
30 April 2024

30 April 2025

Quick facts

Lead sponsor	Taipei Medical University WanFang Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	30 January 2022
Primary completion	30 April 2024
Estimated completion	30 April 2025
Sites	2 locations across Taiwan

Drugs / interventions tested

fucoidan — full drug profile →

Conditions studied

Cachexia — all drugs for Cachexia →

Sponsor

Taipei Medical University WanFang Hospital

Who can join

Adults 20 to 90, any sex, with Cachexia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Fucoidan also ameliorates tumour and chemotherapy-induced muscle atrophy and -related cachectic symptoms in vivo and in vitro. To evaluate the effect of fucoidan in cancer cachexia or sarcopenia in cancer patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy.
Godiyal Y, Maheshwari D, Taniguchi H, Zinzuwadia SS, et al · · 2024 · cited 21× · PMID 39690423 · DOI 10.1186/s40779-024-00586-9
Ten Years of Research on Fucoidan and Cancer: Focus on Its Antiangiogenic and Antimetastatic Effects.
Turrini E, Maffei F, Fimognari C. · · 2023 · cited 18× · PMID 37233501 · DOI 10.3390/md21050307
Cancer cachexia: molecular basis and therapeutic advances.
Tan Y, Xue R, Pan Y, He Z, et al · · 2026 · cited 3× · PMID 41526343 · DOI 10.1038/s41392-025-02331-7

Verify or expand the search:

Other trials of fucoidan

Trials testing the same drug.

NCT05616507 — Oligo-Fucoidan Decrease Lung Radiation Damage · NA · unknown

Other recruiting trials for Cachexia

Currently open trials in the same condition.

NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
NCT07338487 — A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Canc · Phase 1 · recruiting
NCT07288619 — Therapeutic Efficacy of Nutritional Supplementation in Cachexia Associated With Chronic Pulmonary Disease · NA · active not recruiting
NCT06989437 — A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif · Phase 2, PHASE3 · recruiting
NCT07130981 — Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients · recruiting

Other Taipei Medical University WanFang Hospital trials

Trials by the same sponsor.

NCT07401017 — The Effects of Rosuvastatin on Running Training Adaptation and Safety · NA · not yet recruiting
NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
NCT07150182 — Shared Decision-Making for Families in Critical Dialysis Initiation · NA · not yet recruiting
NCT06834425 — Efficacy of NSAID Peritendinous Injection for Acute Tendinitis · NA · active not recruiting
NCT06862297 — Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05623852 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University WanFang Hospital
Last refreshed: 21 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05623852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing